How many institutions held CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in Q1 2024?

74 institutional investors reported CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share for Q1 2024. Use the holders table for investor-level position and value details.

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Q: What does CUSIP 22978P106 represent in this 13F holders report?

CUSIP 22978P106 is the security identifier for CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 22978P106

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 43,411,663
Total 13F shares: 16,387,055
Share change: +1,512,648
Total reported value: $30,971,606
Put/Call ratio: 303%
Price per share: $1.89
Number of holders: 74
Value change: +$2,715,659
Number of buys: 23
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 22978P106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Slate Path Capital LP	13F	Company	5.5%	2,402,455	$6,342,481	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	5.4%	2,338,765	$6,174,340	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	4.9%	2,132,905	$5,630,869	—	31 Dec 2023	13F
Bleichroeder LP	13F	Company	4%	1,755,028	$4,633,274	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	813,285	$2,147,353	—	31 Dec 2023	13F
Cameron Gray	3/4/5	Director	— class O/S missing	687,049	$1,896,255	—	14 Jun 2022	3/4/5
Mark E. Strome	13D/G	—	5%	2,166,242	$1,862,968	$0	14 Nov 2022	13D/G
STATE STREET CORP	13F	Company	1.6%	683,695	$1,804,955	—	31 Dec 2023	13F
Robertson Stephens Wealth Management, LLC	13F	Company	1.1%	478,500	$1,263,240	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.1%	457,985	$1,209,441	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.88%	381,367	$1,006,809	—	31 Dec 2023	13F
Monaco Asset Management SAM	13F	Company	0.79%	342,242	$903,519	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.63%	275,645	$727,703	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.61%	266,227	$702,840	—	31 Dec 2023	13F
ADVISORY RESEARCH INC	13F	Company	0.59%	257,225	$679,074	—	31 Dec 2023	13F
STIFEL FINANCIAL CORP	13F	Company	0.45%	193,975	$512,095	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.44%	191,536	$505,655	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.38%	164,706	$434,824	—	31 Dec 2023	13F
Carlson Capital, L.P.	13F	Company	0.28%	120,000	$316,800	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.25%	109,353	$288,692	—	31 Dec 2023	13F
Sigma Planning Corp	13F	Company	0.25%	108,875	$287,430	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	105,691	$279,024	—	31 Dec 2023	13F
Good Life Advisors, LLC	13F	Company	0.23%	100,000	$264,000	—	31 Dec 2023	13F
UBS Group AG	13F	Company	0.23%	99,261	$262,049	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.2%	87,200	$230,000	—	31 Dec 2023	13F
HighTower Advisors, LLC	13F	Company	0.18%	78,110	$206,000	—	31 Dec 2023	13F
Annandale Capital, LLC	13F	Company	0.15%	65,000	$172,000	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.13%	58,324	$153,975	—	31 Dec 2023	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.13%	57,888	$152,824	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.13%	55,529	$146,597	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.13%	54,629	$144,220	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.12%	50,818	$134,159	—	31 Dec 2023	13F
Squarepoint Ops LLC	13F	Company	0.1%	43,612	$115,136	—	31 Dec 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.08%	33,439	$88,279	—	31 Dec 2023	13F
Baker Avenue Asset Management, LP	13F	Company	0.07%	32,378	$85,478	—	31 Dec 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.07%	31,750	$83,814	—	31 Dec 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	29,801	$78,674	—	31 Dec 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	29,422	$77,674	—	31 Dec 2023	13F
Nantahala Capital Management, LLC	13F	Company	0.06%	26,692	$70,467	—	31 Dec 2023	13F
Navalign, LLC	13F	Company	0.06%	25,000	$66,000	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.05%	22,441	$59,244	—	31 Dec 2023	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.05%	22,200	$59,000	—	31 Dec 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.05%	22,340	$58,978	—	31 Dec 2023	13F
Wedmont Private Capital	13F	Company	0.05%	20,000	$57,200	—	31 Dec 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	18,231	$49,000	—	31 Dec 2023	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.04%	17,888	$47,224	—	31 Dec 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.04%	16,724	$44,151	—	31 Dec 2023	13F
Invesco Ltd.	13F	Company	0.04%	15,342	$40,503	—	31 Dec 2023	13F
XTX Topco Ltd	13F	Company	0.04%	15,304	$40,403	—	31 Dec 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	14,558	$38,433	—	31 Dec 2023	13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2024

As of 31 Mar 2024, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,387,055 shares. The largest 10 holders included Bleichroeder LP, Slate Path Capital LP, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Robertson Stephens Wealth Management, LLC, DIMENSIONAL FUND ADVISORS LP, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

Holder diff

-6

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.